In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adamis Pharmaceuticals Corp.

www.adamispharmaceuticals.com

Latest From Adamis Pharmaceuticals Corp.

Asia Deal Watch: Daiichi Sankyo Acquires Partial Asian Rights To Three Astellas Drugs

Daiichi Sankyo obtains rights to antiemetic Nasea and the anti-hypertension drugs Perdipine and Oldeca. Mitsubishi Tanabe licenses Asian rights to Viela’s inebilizumab for a rare eye disorder.

Deals Business Strategies

Sandoz Seeks Help From Doctors For US Symjepi Push

Sandoz is encouraging US doctors to write prescriptions for epinephrine that include its Symjepi pre-filled syringes, and not just for auto-injector devices, as it targets the retail sector.

Strategy Generic Drugs

Resubmission After Withdrawal: US FDA’s Mavenclad Approval Acknowledges Long Regulatory History

EMD Serono’s multiple sclerosis drug joins small cadre of products that survived a refuse to file letter and NDA withdrawal; chart details recent RTFs and application withdrawals.

Drug Approval Standards Drug Review

Keeping Track Of Non-Oncology Review and Approval News: Erectile Dysfunction, Parkinson's, Cholesterol

The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Adamis Pharmaceuticals Corp.
  • Senior Management
  • Dennis J Carlo, PhD, Pres. & CEO
    Robert O Hopkins, VP, CFO
    Ronald B Moss, MD, CMO
    David J Marguglio, SVP, CBO
  • Contact Info
  • Adamis Pharmaceuticals Corp.
    Phone: (858) 997-2400
    11682 El Camino Real
    Ste. 300
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register